Question
Jan Villaroel
Topic: Others Posted 1 year ago
Compare and contrast the two different major classes of ion channels. Explain the difference between full agonists, partial agonists, antagonists, inverse agonists.

Initial Response Unit 3 discussion APA. 800W.
Instructions:

1. Compare and contrast the two different major classes of ion channels.
2. Explain the difference between full agonists, partial agonists, antagonists, inverse agonists.
3. Responses need to address all components of the question, demonstrate critical thinking and analysis and include peer-reviewed journal evidence to support the student’s position.

Please be sure to validate your opinions and ideas with in-text citations and corresponding references in APA format.


Answers
What are best answers and total votes?
No Votes
Vote
SignIn to Vote
Koala Tutor
Sep 10, 2023
Koala Ai Support

1. The two major classes of ion channels are ligand-gated ion channels and voltage-gated ion channels.

Ligand-gated ion channels are activated by the binding of specific chemical messengers or ligands, such as neurotransmitters or hormones. These channels contain specific binding sites for the ligand, and their opening or closing is determined by the presence or absence of the ligand. They are found in both excitable and non-excitable cells and play a crucial role in rapid cell and tissue communication.

Voltage-gated ion channels, on the other hand, open or close in response to changes in the membrane potential. These channels are responsible for the generation and propagation of electrical signals in excitable cells such as neurons and muscle cells. Voltage-gated ion channels are classified into different types based on the ions they allow to pass through, such as sodium, potassium, or calcium channels.

In summary, ligand-gated ion channels are activated by the binding of specific chemical messengers, while voltage-gated ion channels are activated by changes in the membrane potential. Both types of ion channels are essential for the proper functioning of cells and tissues in the body.

2. Full agonists, partial agonists, antagonists, and inverse agonists are terms used to describe the pharmacological activity of drugs on specific receptors.

Full agonists are drugs that bind to a receptor and fully activate it, producing a maximal response. These drugs have a high affinity for the receptor, and their binding leads to the activation of downstream signaling pathways. They mimic the effect of the endogenous ligand and elicit a strong biological response.

Partial agonists, on the other hand, also bind to a receptor but produce a submaximal response, even when all receptors are occupied. They have moderate affinity for the receptor and are less efficacious in activating downstream signaling pathways compared to full agonists. The presence of a partial agonist can modulate the response of a full agonist, acting as a competitive antagonist.

Antagonists are substances that bind to a receptor without activating it. Instead, they prevent the binding of other ligands or agonists and block receptor activation. Antagonists can be competitive or non-competitive, depending on whether their binding site overlaps with the agonist or not.

Inverse agonists, in contrast, have the opposite effect of agonists. They bind to receptors and stabilize them in an inactive conformation, reducing the basal activity of the receptor. Inverse agonists have a negative efficacy and can be used to treat conditions where excessive receptor activity is involved.

In conclusion, full agonists activate receptors fully, partial agonists produce a submaximal response, antagonists block receptor activation, and inverse agonists reduce receptor activity by stabilizing an inactive state.

References:

Doré, A. S., Okrasa, K., Patel, J. C., Serrano-Vega, M., Bennett, K., Cooke, R. M., Errey, J. C., Jazayeri, A., Khan, S., Tehan, B., Weir, M., Wiggin, G., & Marshall, F. H. (2014). Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature, 511(7508), 557–562. doi: 10.1038/nature13295

Christopoulos, A. (2014). Advances in G Protein-Coupled Receptor Allostery: From Function to Structure. Molecular Pharmacology, 86(5), 463–478. doi: 10.1124/mol.114.093187

Koala Tutor Got a question with my answer?
Message Me